The comparison of the quality of life (QoL) between two different groups of patients with atrial fibrillation (AF) depending on their anticoagulant treatment; those that receive dabigatran (DB) and those who receive acenocoumarol (AC).Fifty patients received AC and 50 patients received DB. The Euro Quality of Life-15D (EQ-15D and the Atrial Fibrillation Effect on Quality-of-Life (AFEQT), where used to assess the quality of life of patients with AF. The statistical analysis was performed using the statistical software SPSS version 19.0. There was no significant difference at the total score of EQ-15D and AFEQT between the two groups of patients (p>0.05). The mean score of EQ-15D for AC was 60.6±9.6 vs. 62.7±9.5 for DB and the mean score of AFEQT for AC was 69.1 ±19.8 vs. 73.1±17.2 for DB. Despite the fact that AC is a treatment definitely more demanding than DB the quality of the patient’s life in Greece is not affected by the different treatment.
Keywords: Atrial Fibrillation; anticoagulation therapy; Quality of Life; Dabigatran Etexilate; Acenocoumarol, Warfarin;Quality of Life questionnaires.